Alphonse Galdes
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alphonse Galdes.
Peptides | 1992
Theo L. Peeters; Mark J. Macielag; Inge Depoortere; Zenon D. Konteatis; James R. Florance; Ralph A. Lessor; Alphonse Galdes
A recent systematic study of porcine motilin fragments has clearly shown that biological activity resides in the amino-terminal end. The amino-terminal tetradecapeptide retains more than 90% of the potency of the full molecule. We now examined the effect of replacement of residues 1 through 11 by either their D-isomer or by alanine in [Leu13]pMOT(1-14). Peptides were synthesized using Fmoc solid phase methodology, purified by HPLC, and assayed for their ability to displace bound motilin (rabbit antral smooth muscle homogenate) and to induce contractions (isolated rabbit duodenal segments). The negative logarithm of the concentration displacing 50% of the tracer (pIC50), or producing 50% of the maximal contractile response (pEC50), was determined. All compounds were still full agonists. A reduction in potency of more than two log units was seen for the compounds in which residues 1 (Phe), 4 (Ile), and 7 (Tyr) were replaced by Ala and residues 3 (Pro), 4 (Ile), and 6 (Thr) by their D-isomer. The largest drop was noted for the analogs substituted at position 4. For all compounds there was an almost perfect correlation between the pIC50 and the pEC50 values (r = 0.96), although the pEC50 was consistently smaller. These results show that the biological activity of motilin is mainly determined by the first seven residues. The pharmacophore consists of the aromatic rings from Phe1 and Tyr7 and the aliphatic side chains from Val2 and Ile4. Pro3, Phe5, and Thr6 may stabilize the bioactive conformation.
Peptides | 1992
Mark J. Macielag; Theo L. Peeters; Zenon D. Konteatis; James R. Florance; Inge Depoortere; Ralph A. Lessor; Lance A. Bare; Yea-Shun Cheng; Alphonse Galdes
Several peptide fragments representing N-terminal, C-terminal, and internal sequences of [Leu13]porcine motilin ([Leu13]pMOT) were synthesized using Fmoc solid phase methodology. Peptides were assayed for motilin receptor binding activity in a rabbit antrum smooth muscle preparation and for stimulation of contractile activity in segments of rabbit duodenum. In vitro activity was directly correlated with motilin receptor binding affinity for all [Leu13]pMOT fragments examined. N-Terminal fragments of just over half the length of the native peptide are nearly equipotent as full-length motilin. These results suggest that the N-terminal segment, together with residues from the mid-portion of the molecule, constitutes the bioactive portion of pMOT. The C-terminal segment, in contrast, contributes little to receptor binding affinity or in vitro activity.
Journal of Chromatography A | 1991
James R. Florance; Zenon D. Konteatis; Mark J. Macielag; Ralph A. Lessor; Alphonse Galdes
Motilin is a gut hormone, which is involved in gastrointestinal motility. Capillary electrophoresis studies were made on 24 peptides that are N-terminal, C-terminal or internal fragments of motilin. The isoelectric point, total charge and hydrophobicity were calculated for all of the peptides. The effects of buffers and pH on migration time and resolution were studied. These included citrate buffer, pH 2.5; phosphate buffer, pH 7.0 and borate buffer, pH 10.0. A capillary zone electrophoresis method was developed to resolve 14 of the motilin peptides. Secondary structure predictions were made using the Chou-Fasman method. Circular dichroism spectra were collected to confirm presence of alpha-helix in several fragments. Effects of charge, hydrophobicity, secondary structure and length of the motilin fragments on migration time were studied.
Advances in Enzymology and Related Areas of Molecular Biology | 2006
Bert L. Vallee; Alphonse Galdes
Protein Science | 1993
Jack J. Skalicky; D. Joseph Ciesla; Arthur Pardi; William J. Metzler; Alphonse Galdes
Biochemistry | 1983
Kieran F. Geoghegan; Alphonse Galdes; Richard A. Martinelli; Barton Holmquist; David S. Auld; Bert L. Vallee
Biochemistry | 1989
Arthur Pardi; Alphonse Galdes; James R. Florance; Duane Maniconte
Biochemistry | 1986
Alphonse Galdes; David S. Auld; Bert L. Vallee
Biochemistry | 1983
Alphonse Galdes; David S. Auld; Bert L. Vallee
European Journal of Pharmacology | 1995
Inge Depoortere; Marc Macielag; Alphonse Galdes; Theo L. Peeters